Cargando…

Immunogenicity of pneumococcal vaccination in HIV infected individuals: A systematic review and meta-analysis

BACKGROUND: The objective of this systematic review and meta-analysis was to summarise the literature regarding the immunogenicity of pneumococcal conjugate vaccines (PCV) and pneumococcal polysaccharide vaccines (PPSV) in adult people living with HIV (PLWH) in the era of advanced combination antire...

Descripción completa

Detalles Bibliográficos
Autores principales:	Garrido, Hannah M.Garcia, Schnyder, Jenny L., Tanck, Michael W.T., Vollaard, Albert, Spijker, René, Grobusch, Martin P., Goorhuis, Abraham
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Research paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7695973/ https://www.ncbi.nlm.nih.gov/pubmed/33294820 http://dx.doi.org/10.1016/j.eclinm.2020.100576

Ejemplares similares

Immunogenicity of the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Followed by the 23-Valent Pneumococcal Polysaccharide Vaccine (PPSV23) in Adults with and without Immunosuppressive Therapy
por: Garcia Garrido, Hannah M., et al.
Publicado: (2022)

2939. Hepatitis A vaccine immunogenicity in an immunocompromised population: a prospective cohort study
por: Schnyder, Jenny, et al.
Publicado: (2023)

Incidence and Risk Factors for Invasive Pneumococcal Disease and Community-acquired Pneumonia in Human Immunodeficiency Virus–Infected Individuals in a High-income Setting
por: Garcia Garrido, Hannah M, et al.
Publicado: (2020)

Immunogenicity of a 5‐dose pneumococcal vaccination schedule following allogeneic hematopoietic stem cell transplantation
por: Garcia Garrido, Hannah M., et al.
Publicado: (2022)

Fractional dose of intradermal compared to intramuscular and subcutaneous vaccination - A systematic review and meta-analysis
por: Schnyder, Jenny L., et al.
Publicado: (2020)

Delayed large local reaction to the adenovirus-vectored (ChAdOx1) vaccine
por: Grobusch, Martin P., et al.
Publicado: (2021)

Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine in HIV-infected individuals naive to pneumococcal vaccination
por: Bhorat, As’ad E., et al.
Publicado: (2015)

P1523: IMMUNOGENICITY OF THE 13-VALENT PNEUMOCOCCAL CONJUGATED VACCINE FOLLOWED BY THE 23-VALENT POLYSACCHARIDE VACCINE IN CHRONIC LYMPHOCYTIC LEUKEMIA
por: Haggenburg, Sabine, et al.
Publicado: (2023)

Safety, immunogenicity and efficacy of pneumococcal conjugate vaccine in HIV-infected individuals
por: Nunes, Marta C., et al.
Publicado: (2012)

Immunogenicity of the 13-Valent Pneumococcal Conjugated Vaccine Followed by the 23-Valent Polysaccharide Vaccine in Chronic Lymphocytic Leukemia
por: Haggenburg, Sabine, et al.
Publicado: (2023)

SARS-CoV-2 vaccination for patients with inflammatory bowel disease
por: Garrido, Hannah M Garcia, et al.
Publicado: (2021)

Immunogenicity and Efficacy of Pneumococcal Conjugate Vaccine (Prevenar13(®)) in Preventing Acquisition of Carriage of Pneumococcal Vaccine Serotypes in Tanzanian Children With HIV/AIDS
por: Makenga, Geofrey, et al.
Publicado: (2021)

Incidence and Predictors of Community-Acquired Pneumonia in Patients With Hematological Cancers Between 2016 and 2019( )
por: Certan, Maria, et al.
Publicado: (2022)

Response to Pneumococcal Polysaccharide Vaccination in Newly Diagnosed HIV-Positive Individuals
por: Leggat, David J, et al.
Publicado: (2015)

Safety and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, in adults living with HIV
por: Mohapi, Lerato, et al.
Publicado: (2022)

Pneumococcal conjugate vaccination schedules in infants—acquisition, immunogenicity, and pneumococcal conjugate and yellow fever vaccine co-administration study
por: Mackenzie, Grant A., et al.
Publicado: (2022)

Recent Topics of Pneumococcal Vaccination: Indication of Pneumococcal Vaccine for Individuals at a Risk of Pneumococcal Disease in Adults
por: Asai, Nobuhiro, et al.
Publicado: (2021)

Systematic Review of the Effect of Pneumococcal Conjugate Vaccine Dosing Schedules on Immunogenicity
por: Deloria Knoll, Maria, et al.
Publicado: (2014)

Maintenance of an Immunogenic Response to Pneumococcal Vaccination in Children With Sickle Cell Disease
por: Rahim, Mahvish Q., et al.
Publicado: (2022)

Pneumococcal Surface Proteins as Virulence Factors, Immunogens, and Conserved Vaccine Targets
por: Aceil, Javid, et al.
Publicado: (2022)

Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine compared to the 23-valent pneumococcal polysaccharide vaccine in elderly Japanese adults
por: Shiramoto, Masanari, et al.
Publicado: (2015)

A phase 3 study of safety and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, followed by 23-valent pneumococcal polysaccharide vaccine, in children with HIV
por: Wilck, Marissa, et al.
Publicado: (2023)

Safety and Immunogenicity of Measles Vaccination in HIV-Infected and HIV-Exposed Uninfected Children: A Systematic Review and Meta-Analysis
por: Mutsaerts, Eleonora A.M.L., et al.
Publicado: (2018)

Intradermal immunization—a dose-sparing strategy to combat global shortages of severe acute respiratory syndrome coronavirus 2 vaccines?
por: Schnyder, Jenny L., et al.
Publicado: (2022)

Immunogenicity and seroefficacy of 10-valent and 13-valent pneumococcal conjugate vaccines: a systematic review and network meta-analysis of individual participant data
por: Feng, Shuo, et al.
Publicado: (2023)

Pneumococcal vaccination in persons living with HIV: Pneumococcal conjugate, polysaccharide or both?
por: Dhingra, Bhavna, et al.
Publicado: (2020)

Comparison of immunogenicity and safety of an influenza vaccine administered concomitantly with a 13-valent pneumococcal conjugate vaccine or 23-valent polysaccharide pneumococcal vaccine in the elderly
por: Seo, Yu Bin, et al.
Publicado: (2017)

Immunogenicity and 1-year boostability of a three-dose intramuscular rabies pre-exposure prophylaxis schedule in adults receiving immunosuppressive monotherapy: a prospective single-centre clinical trial
por: Garcia Garrido, Hannah M, et al.
Publicado: (2022)

Immunogenicity of pneumococcal vaccination in a patient with sickle hemoglobinopathy: a case report
por: Clay, E Leila Jerome, et al.
Publicado: (2015)

1242. Safety and Immunogenicity of Novel 24-Valent Pneumococcal Vaccine in Healthy Adults
por: Chichili, Gurunadh, et al.
Publicado: (2020)

A Systematic Review and Meta-Analysis of Anti-Rheumatic Drugs and Pneumococcal Vaccine Immunogenicity in Inflammatory Arthritis
por: Nagra, Deepak, et al.
Publicado: (2023)

The Differential Impact of Coadministered Vaccines, Geographic Region, Vaccine Product and Other Covariates on Pneumococcal Conjugate Vaccine Immunogenicity
por: Park, Daniel E., et al.
Publicado: (2014)

Predicting vaccine effectiveness against invasive pneumococcal disease in children using immunogenicity data
por: Ryman, Josiah, et al.
Publicado: (2022)

Brief communication: immunogenicity of measles vaccine when co-administered with 10-valent pneumococcal conjugate vaccine
por: Toh, Zheng Quan, et al.
Publicado: (2020)

Immunogenicity and Reactogenicity of Vaccine Boosters after Ad26.COV2.S Priming
por: Sablerolles, Roos S.G., et al.
Publicado: (2022)

COVID-19 impact on EuroTravNet infectious diseases sentinel surveillance in Europe
por: Grobusch, Martin P., et al.
Publicado: (2023)

Population versus individual protection by pneumococcal conjugate vaccination
por: Klugman, Keith P, et al.
Publicado: (2019)

Safety and immunogenicity of a multivalent pneumococcal conjugate vaccine given with 13-valent pneumococcal conjugate vaccine in healthy infants: A phase 2 randomized trial
por: Simon, Michael W., et al.
Publicado: (2023)

Covid-19 vaccine trials: Ethnic diversity and immunogenicity
por: Jethwa, Hannah, et al.
Publicado: (2021)

Lipidation of Pneumococcal Antigens Leads to Improved Immunogenicity and Protection
por: Voß, Franziska, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_njj3533gm064ghmesadvttuotp